Quantcast

Latest Single-nucleotide polymorphism Stories

2014-04-08 10:48:49

Genetic variants associated with enjoying the effects of d-amphetamine—the active ingredient in Adderall—are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder (ADHD).

2014-03-28 09:30:17

Researchers have pinpointed a new mechanism of how natural variation in our DNA alters an individual's risk for developing heart disease by interfering with the ability of a developmental gene to interact with a specialized type of RNA.

2014-01-25 23:00:17

Genome ID Group, LLC, d/b/a, The Center for Advanced Forensic DNA Analysis TM (CAFDA) is pleased to announce the appointment of Sandra L. Close (Kirkwood) PhD.

More Than 40 New Genetic Links To Rheumatoid Arthritis Discovered
2013-12-26 08:06:07

An international team of scientists has uncovered more than 40 new genes, pathways and cell types linked to an increased risk of rheumatoid arthritis, according to research published Wednesday in the online edition of the journal Nature.

Stress Gene Linked Heart Attacks
2013-12-19 12:03:34

A new study reveals that the genetic trait responsible for predisposing some people to strong stress reactions may also cause the risk of heart attack or death to rise by 38 percent.

2013-11-11 10:59:10

Coding variants in immune disease-related genes play only a small part in the overall genetic risk for psoriasis.

Cucumber Genome Resequenced Revealing An Evolutionary Enigma
2013-10-21 04:42:19

Large-scale, deep re-sequencing of 115 cucumbers worldwide has led to the creation of a genomic variation map for the vegetable that includes 3.6 million variants, an international team of scientists report in a new study.

Genetic Variation Fuels Testicular Cancer
2013-10-11 04:33:32

Using a genomic analysis, a team of international researchers has identified a specific mutation responsible for a dramatic increase in the risk for testicular cancer.

2013-10-02 14:08:11

The discovery of genetic differences affecting up to a third of the population could take the guesswork out of prescribing the correct dose of 25 percent of drugs currently on the market, researchers say.